C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/38 (2006.01) A61K 39/25 (2006.01) A61K 39/42 (2006.01) C07K 14/04 (2006.01) C07K 16/08 (2006.01) C12N 5/10 (2006.01) C12N 15/85 (2006.01) C12P 21/08 (2006.01) G01N 33/569 (2006.01) G01N 33/577 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2068654
The present invention relates to the construction of a recombinant plasmid which is capable of expressing a secretory trun-cated glycoprotein (Tgp) of Varicella-zoster virus (BZV) in mammalian cells. The secretory Tgp of the present invention contains at least one epitope capable of inducing antibody response. the present invention comtemplates the production and utilization of this secretory Tgp in a vaccine against chickenpox and/or shingles. The present invention is also directed towards the use of the secretory Tgp in diagnostic assays for detection of VZV. The present invention is also directed to first antibodies specific to secre-tory Tgp and to second antibodies specific to the first antibodies. These second antibodies are also useful in diagnostic assays for VZV.
Mcfadden Fincham
Research Corporation Technologies Inc.
LandOfFree
Varicella-zoster virus antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Varicella-zoster virus antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Varicella-zoster virus antigen will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1802191